West Pharmaceutical Services Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $235.9M | $203.0M | $274.6M | $255.3M | $230.0M | $161.9M | $91.8M | $110.2M |
| Accounts Receivable | $253.2M | $200.5M | $181.4M | $179.0M | $185.7M | $175.0M | $147.2M | $126.4M |
| Inventory | $215.2M | $199.3M | $181.1M | $181.5M | $176.9M | $162.2M | $151.8M | $147.0M |
| Total Current Assets | $743.5M | $641.9M | $673.7M | $659.1M | $650.7M | $557.3M | $472.0M | $436.6M |
| Property, Plant & Equipment | $855.0M | $778.3M | $721.0M | $705.8M | $711.7M | $669.0M | $593.6M | $554.8M |
| Goodwill | $107.7M | $103.0M | $104.6M | $108.6M | $114.2M | $112.5M | $111.5M | $112.5M |
| Intangible Assets (Excl. Goodwill) | $21.7M | $23.3M | $37.6M | $42.0M | $48.3M | $50.6M | $52.0M | $55.1M |
| Total Assets | $1.86B | $1.72B | $1.70B | $1.67B | $1.67B | $1.56B | $1.40B | $1.29B |
| Liabilities | ||||||||
| Accounts Payable | $138.1M | $122.0M | $119.8M | $103.1M | $108.0M | $102.9M | $89.8M | $63.2M |
| Total Current Liabilities | $279.5M | $241.0M | $314.3M | $252.5M | $236.9M | $261.8M | $243.2M | $169.7M |
| Long-Term Debt | $197.0M | $226.2M | $228.9M | $308.3M | $371.3M | $378.8M | $299.3M | $358.1M |
| Total Liabilities | $582.9M | $599.2M | $671.2M | $712.8M | $765.2M | $835.1M | $744.2M | $668.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $1.18B | $1.07B | $964.6M | $902.2M | $805.0M | $719.9M | $664.5M | $612.6M |
| Total Stockholders' Equity | $1.28B | $1.12B | $1.02B | $956.9M | $906.4M | $728.9M | $654.9M | $625.7M |